Metagenomi Therapeutics Inc.
XNAS:MGX
| Market Cap (Intraday) | 40.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.15 |
| 50-Day MA | $1.21 |
| 200-Day MA | $1.41 |
Metagenomi Inc. Stock, XNAS:MGX
5959 Horton Street, 7th floor, Emeryville, California 94608
United States of America
Phone: +1.510.871.4880
Number of Employees: 202
Description
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editÃ?Âing toolbox, therÃ?ÂaÃ?ÂpeuÃ?Âtic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.